A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
Clinical trial NCT02320435 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02320435
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-02
- Primary completion
- 2026-12-31
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.